NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PAR-22-248 from the NIH Guide for Grants and Contracts. The purpose of this NIH Mentored Research Scientist Development Award (K01) is to provide salary and research support to investigators who are within ten years of completing their terminal professional degree or residency training. Research and mentorship must be in the field of HIV/AIDS translational studies, using nonhuman primates (NHPs) as preclinical models. These awards will provide 3 years of support for intensive research career development under the guidance of an experienced mentorship team, with expertise in both the pre-clinical application of NHP HIV/AIDS models and in translation of the results from such studies to clinical application in humans. The expectation is that this sustained experience will launch independent research careers and enable awardees to become competitive for new research project grant (e.g., R01) funding. This funding initiative addresses research priorities of the fiscal year (FY) 2021-2025 NIH Strategic Plan for HIV and HIV-Related Research (https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan): reduce the incidence of HIV; develop next-generation HIV therapies; research toward HIV cure; and address HIV-associated comorbidities, coinfections, and complications. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Those proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA (FOA #).
Notice NOT-GM-23-012 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-OH-23-003 from the NIH Guide for Grants and Contracts. The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for Education and Research Centers (ERCs) that are focused on occupational safety and health training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the primary means for meeting this mandate.
Notice NOT-OD-23-012 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-011 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-249 from the NIH Guide for Grants and Contracts. This funding opportunity seeks to support the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program. The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a more robust national cancer program and address challenges in cancer and cancer disparities research, education, and outreach, as well as their impact on underserved populations. The institutions in each partnership are expected to work collaboratively to 1) increase the cancer research and cancer research education capacity of the ISUPSs; 2) increase the number of students and investigators from underrepresented populations engaged in cancer research; 3) improve the effectiveness of CCs in developing and sustaining research programs focused on cancer health disparities and increase the number of investigators and students conducting cancer health disparities research, and 4) develop and implement cancer-related activities that benefit the surrounding underserved communities.
Funding Opportunity PAR-22-239 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major goal of the NCI P20 partnership programs is to provide support for investigators at ISUPS and Cancer Centers to conduct cancer research pilot projects and cancer research education program. The purpose of the pilot projects and education program is to allow awardees to obtain preliminary data that will lead to competitive grant applications for funding by the NIH/NCI and/or other Federal/Non-Federal agencies.
Notice NOT-OD-23-007 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-23-032 from the NIH Guide for Grants and Contracts. Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Notice NOT-TR-23-003 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-008 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-006 from the NIH Guide for Grants and Contracts
Notice NOT-TR-23-002 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-139 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-138 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-141 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-009 from the NIH Guide for Grants and Contracts
Notice NOT-DK-22-033 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-005 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-ES-22-007 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications that further examine and characterize molecular underpinnings surrounding telomere status and accompanying biological pathways in response to environmental insults. Specifically, the intent is to further stimulate the field on how general telomere maintenance modulates downstream biological pathway(s) leading to cellular and organismal dysfunction. It is anticipated that proposed studies examining exposure affects at telomeric regions can actually potentiate early onset of age-related diseases. This FOA ultimately seeks to identify key mechanistic insights into telomere dynamics and how this could better dissect the interplay between environmental exposures at this vulnerable site contribute to disease (e.g., cancer, CVD, and other age-related outcomes, such as neurodegeneration).